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Introduction
Adult stem cells and progenitor cells can integrate and respond
to appropriate extracellular stimuli in the form of hormones
and growth factors, or contact with the extracellular matrix
(ECM) and neighboring cells. The delicate balance between
the dormancy of progenitor cells and their timely proliferation
and differentiation is a crucial parameter in tissue homeostasis
that is often perturbed in disease. In vitro studies and animal
implant experiments have revealed the multipotential nature of
mesenchymal stem cells, which contribute to the regeneration
of mesenchymal tissues such as bone, cartilage, muscle,
tendon, stroma and adipose tissues (Pittenger et al., 1999;
Prockop, 1997).
Adipogenesis is a complex process characterized by the
strict temporal regulation of multiple and interacting signaling
events that ultimately lead to the expression of adipocyte-
specific genes (Gregoire et al., 1998; Rosen and Spiegelman,
2000). A cascade of transcription factors is induced that
involves the sequential activation of the CCAAT/enhancer-
binding proteins (C/EBPs) and the peroxisome proliferator-
activated receptor g (PPARg ), which leads to the activation of
several genes, such as those responsible for lipid transport and
metabolism. Initially, fibroblastic preadipocytes stop dividing
and acquire a rounded morphology. The change of shape from
fibroblastic preadipocytes to rounded, mature adipocytes is
accompanied by changes in cytoskeletal organization and
contacts with the ECM. The expression of fibronectin,
integrins, actin and several cytoskeletal proteins is
downregulated during adipogenesis (Rodriguez Fernandez and
Ben-Ze’ev, 1989; Spiegelman and Farmer, 1982). In fact, the
disruption of contacts with the ECM is a requirement for
adipocyte differentiation (Spiegelman and Ginty, 1983). 
Our understanding of the molecular events involved in
adipogenesis is based mainly on in vitro, cell culture models,
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Changes in cell shape are a morphological hallmark of
differentiation. In this study we report that the expression
of ADAM12, a disintegrin and metalloprotease,
dramatically affects cell morphology in preadipocytes,
changing them from a flattened, fibroblastic appearance to
a more rounded shape. We showed that the highest levels
of ADAM12 mRNA were detected in preadipocytes at the
critical stage when preadipocytes become permissive for
adipogenic differentiation. Furthermore, as assessed by
immunostaining, ADAM12 was transiently expressed at the
cell surface concomitant with the reduced activity of b 1
integrin. Co-immunoprecipitation studies indicated the
formation of ADAM12/b 1 integrin complexes in these
preadipocytes. Overexpression of ADAM12 at the cell
surface of 3T3-L1 preadipocytes achieved by transient
transfection or retroviral transduction led to the
disappearance of the extensive network of actin stress
fibers that are characteristic of these cells, and its
reorganization into a cortical network located beneath the
cell membrane. The cells became more rounded, exhibited
fewer vinculin-positive focal adhesions, and adhered less
efficiently to fibronectin in attachment assays. Moreover,
ADAM12-expressing cells were more prone to apoptosis,
which could be prevented by treating the cells with
b 1-activating antibodies. A reduced and re-organized
fibronectin-rich extracellular matrix accompanied these
changes. In addition, b 1 integrin was more readily
extracted with Triton X-100 from cells overexpressing
ADAM12 than from control cells. Collectively, these results
show that surface expression of ADAM12 impairs the
function of b 1 integrins and, consequently, alters the
organization of the actin cytoskeleton and extracellular
matrix. These events may be necessary for early adipocyte
differentiation.
Key words: ADAM12, b 1 integrin, Actin cytoskeleton, Extracellular
matrix, Adipogenesis
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especially 3T3-L1 preadipocytes (Gregoire et al., 1998; Rosen
and Spiegelman, 2000). Several genetically modified mouse
models have also contributed to the current knowledge of
adipocyte differentiation (Moitra et al., 1998; Rosen et al.,
1999; Wang et al., 1995). We have recently reported increased
adipogenesis in transgenic mice overexpressing the disintegrin
and metalloprotease, ADAM12, driven by the muscle creatine
kinase promoter (Kawaguchi et al., 2002). Cells expressing
early markers of adipogenesis were apparent in the perivascular
space in the muscle tissue of 1- to 2-week-old transgenic mice,
whereas mature, lipid-laden adipocytes were seen at 3 to 4
weeks of age, suggesting a crucial role for ADAM12 in
adipogenesis in vivo. 
ADAM12 belongs to the ADAMs, a family of adhesion
proteins and metalloproteases comprising more than 30
members. The prototype ADAM molecule is a transmembrane
protein composed of several distinct domains including a
prodomain, metalloprotease, disintegrin, cysteine-rich, EGF-
like and transmembrane domains, as well as a short
cytoplasmic tail (Black and White, 1998; Schlondorff and
Blobel, 1999). Human ADAM12 exists in two alternatively
spliced forms – a long transmembrane form, ADAM12-L, and
a shorter secreted form, ADAM12-S, which lacks the
transmembrane and cytoplasmic domains (Gilpin et al., 1998).
Only the long, membrane-anchored form of ADAM12 has
been reported in mice (Yagami-Hiromasa et al., 1995). In our
transgenic mouse models, increased adipogenesis occurred in
the skeletal muscle of mice expressing human ADAM12-S,
ADAM12-L, or ADAM12-L lacking the cytoplasmic domain
(ADAM12-D cyt) (Kawaguchi et al., 2002) (U.M.W.,
unpublished), indicating that it is primarily the extracellular
domain of ADAM12 that elicits the robust adipogenic response
observed in these mice. The phenotype of ADAM12-deficient
mice was recently characterized and it was noted that the
interscapular brown adipose tissue was reduced in some pups
(Kurisaki et al., 2003).
The present study was undertaken to elucidate the molecular
mechanisms underlying the stimulatory effects of ADAM12 on
adipocyte differentiation. We present evidence that ADAM12
is transiently expressed at the cell surface just before the onset
of adipogenesis, concomitant with the reduced activity of b 1
integrin, when preadipocytes begin to change their morphology
from a fibroblastic to a rounded shape. Overexpression and
RNAi knockdown experiments show that ADAM12 induces
several changes in b 1 integrin-dependent functions in these
mesenchymal cells. These changes in integrin function appear
to involve lateral associations between ADAM12 and b 1
integrin within the plasma membrane that result in increased
detergent solubility of b 1 integrin. 
Materials and Methods
Cell lines
The following cell lines were used: mouse 3T3-L1 preadipocytes
(ATCC CL173, Rockville, MD), C3H10T1/2 (ATCC CCL-226),
CHO-K1 (ATCC CCL-61) and human liposarcoma LiSa-2 cells
(Wabitsch et al., 2000). All cell lines, except for CHO-K1 and LiSa-
2 cells, were maintained in growth medium consisting of Dulbecco’s
Modified Eagle’s Medium (DMEM) with Glutamax I and 4500 mg/l
glucose, 50 U/ml penicillin, 50 m g/ml streptomycin and 10% fetal
bovine serum (FBS) (Invitrogen, Tåstrup, Denmark). Adipocyte
differentiation of 3T3-L1 cells was induced by treating confluent
cells with DMI, (0.25 m M dexamethasone, 0.5 mM
methylisobutylxanthine, 10 m g/ml insulin) in growth medium for 2
days (Cook et al., 1985; Ntambi and Young-Cheul, 2000). Adipocyte
differentiation of C3H10T1/2 cells was induced by treating confluent
cells with DMI and 1 m M BRL49653 (kindly provided by Novo
Nordisk A/S, Bagsværd, Denmark) in growth medium for 2 days
(Lehmann et al., 1995). CHO-K1 and LiSa-2 cells were maintained
in DMEM/F12 (1:1) (Invitrogen) containing 10% FBS. For
differentiation of LiSa-2 cells, culture medium was replaced with
serum-free DMEM/F12 (1:1) supplemented with 10 m g/ml transferrin,
15 mM HEPES, 1 nM insulin, 20 pM triiodothyronine and 1 m M
cortisol (Wabitsch et al., 2000).
Antibodies 
Antibodies to ADAM12 included mouse monoclonal antibodies
(mAbs) 6E6, 6C10 and 8F8; and polyclonal antibodies rb122 and
rb109 (Kronqvist et al., 2002). Mouse anti-human b 1 integrin (clone
12G10) was obtained from Serotec (Oxford, UK). Rabbit-antiserum
to b 1 integrin was kindly provided by S. Johansson (Bottger et al.,
1989) and mouse monoclonal antibody to vinculin was kindly
provided by M. Glukhova. Mouse anti-human b 1 integrin (clone 18)
and phycoerythrin-conjugated CD29 (clone MAR4), anti-mouse
b 1 integrin (9EG7), anti-human fibronectin Ab (A245) and
phycoerythrin-conjugated goat anti-mouse immunoglobulin G (IgG)
were all obtained from BD Biosciences (Brøndby, Denmark). Mouse
anti-human b 1 integrin (JB1A) was obtained from Chemicon Ltd
(Hampshire, UK). Mouse anti-human b 1 integrin (K20), isotype-
controls, mouse IgG, goat anti-mouse–horse radish peroxidase (HRP)
Ab, and goat anti-rabbit–HRP Ab were obtained from Dako A/S
(Glostrup, Denmark). 
Transient transfections 
Cells were transfected using FuGene 6 transfection reagent (Roche
Diagnostic, Mannheim, Germany) or Lipofectamine (Invitrogen) in
serum-containing medium or Opti-MEM I according to the
manufacturer’s instructions, and analyzed two days later. To create
fusion proteins with enhanced green fluorescent protein (EGFP),
human ADAM12 cDNAs were cloned into the pEGFP-N1 vector
(Clontech Laboratories, Heidelberg, Germany). The following
constructs were used (Hougaard et al., 2000): human ADAM12-L
truncated at nt 2498, resulting in a membrane-inserted protein lacking
the cytoplasmic tail, called ADAM12-D cyt (#1442); and ADAM12-
D cyt with a E351-Q catalytic site mutation (#1455). As a control, the
empty vector, pEGFP-NI (#1422), was used. Mouse full-length
ADAM12 (#1629) (kindly provided by J. Frey) or empty-vector
control pcDNA3 (#1695) (Invitrogen) was transfected into CHO-K1
cells that were used as positive or negative controls, respectively, in
western blots.
Retroviral transduction
ADAM12-D cyt cDNA was subcloned into the SalI site of pBABEpuro
(Morgenstern and Land, 1990) for retroviral transduction, as
described previously (Porse et al., 2001). Briefly, retroviral stocks
were obtained by transiently transfecting Phoenix ecotropic retroviral
packaging cells with pBABE-based proviral constructs. Cell culture
supernatants were harvested and used to infect 3T3-L1 and
C3H10T1/2 cells. After infection, cells were cultured in the presence
of 1 m g/ml puromycin (Sigma-Aldrich, Vallensbaek, Denmark) to
select stable clones.
Northern blot analysis
TriZol reagent (Invitrogen) was used to isolate total RNA from
embryonic muscle, white and brown adipose tissue, or cultured cells
Journal of Cell Science 116 (19)
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at various stages of differentiation. RNA (15 m g total RNA per lane)
was separated on 1% formaldehyde gels and blotted onto Hybond N
nylon membranes (Amersham Pharmacia Biotech, Uppsala, Sweden).
Hybridization was carried out at 68°C for 1 hour using [32P]a -dCTP-
labeled mouse ADAM12, PPAR g (kindly provided by B. M.
Spiegelman), or glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) from Clontech. cDNAs in QuickHyb hybridization solution
(Stratagene, Amsterdam, The Netherlands). After washing with
2· saline sodium citrate (SSC)/1% sodium dodecyl sulphate (SDS),
2· SSC/0.1% SDS and 0.2 · SSC/0.1% SDS twice each at 65°C, the
blots were exposed to Kodak X-OMAT AR film at –80°C with
intensifying screens, or analyzed by a PhosphorImager (Storm840,
Molecular Dynamics, Amersham Biosciences, Hørsholm, Denmark).
Protein extraction, immunoprecipitation and western blot
analysis
Proteins from growing 3T3-L1, C3H10T1/2, LiSa-2 cells and CHO-
K1 cells transfected with control vector (#1695) or mouse full-length
ADAM12 (#1629) were extracted at 4°C in 20 mM Tris, pH 8.0, 150
mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 50 mM octylglucoside, and
a protease inhibitor cocktail (Complete, ethylenediaminetetraacetic
acid-free protease inhibitor cocktail tablets; Roche Molecular
Biochemical, Hvidovre, Denmark). Insoluble material was removed
by a brief centrifugation (100 g for 1 minute), and the supernatant was
further centrifuged at 14,800 g for 45 minutes. The resulting pellets
were extracted for another 30 minutes in the extraction buffer,
incubated overnight at 4°C with a mixture of ADAM12 mAbs (6E6,
6C10 and 8F8; 7.5 m g total), or a control antibody (total IgG
concentration per sample 7.5 m g) and protein-G Sepharose beads
(Amersham Pharmacia Biotech), rinsed twice with extraction buffer
and eluted by boiling in sample buffer. Samples were separated on 8%
polyacrylamide gels. Western blots were performed, as described
previously (Loechel et al., 1998), using a polyclonal anti-ADAM12
antibody (rb122), or – for co-immunoprecipitation studies –
monoclonal antibodies against mouse (clone 18) or human (JB1A) b 1
integrin.
Immunostaining and imaging
Tissue specimens were fixed in formalin and embedded in paraffin.
For immunoperoxidase staining, 4 m m tissue sections were
deparaffinized, subjected to microwave treatments in citrate buffer at
pH 6.0 and incubated with the primary antibody for 25 minutes
at room temperature. Detection was performed using the
DakoChemMate detection kit (code K 5001), which is based on an
indirect streptavidin-biotin technique with a biotinylated secondary
antibody. Cultured cells were analyzed by immunoperoxidase or
immunofluorescence staining on suspended or adherent cells. To stain
suspended cells, cells were detached with trypsin/EDTA or cell
dissociation buffer (both from Invitrogen), restored for 5 minutes at
37°C in growth medium supplemented with 10% FBS, then
transferred to ice and incubated for 30 minutes with antibodies to
ADAM12, fibronectin, vinculin or b 1 integrin. The cells were rinsed
once in PBS then fixed in 4% paraformaldehyde for 2 minutes, and
immediately centrifuged for 2 minutes in a Cytospin microfuge
(Shandon, Pittsburgh, PA) onto glass slides and air-dried. The
secondary antibodies were applied as described above, except that
fluorescein isothiocyanate (FITC)- or tetramethyl rhodamine
isothiocyanate (TRITC)-conjugated secondary antibodies were used
for immunofluorescence staining. Adherent cells cultured on plastic
dishes were fixed with 4% paraformaldehyde for 5 minutes,
permeabilized with 0.1% Triton X-100 for 5 minutes and incubated
with antibodies for 1 hour at room temperature. Secondary antibodies
were applied, and peroxidase staining was performed as described
above. Staining for F-actin was performed with TRITC-phalloidin
(Molecular Probes, Leiden, The Netherlands). Cells were examined
using an inverted Zeiss Axiovert microscope equipped with phase
contrast optics and connected to a PentaMAX chilled charge-coupled
device camera. The images were processed using the Metamorph
Software Program (Universal Imaging Corporation, Brock and
Michelsen; Birkerød, Denmark). To estimate the degree of stress fiber
and focal adhesion formation, more than 600 cells in 20 fields were
analyzed and the percentage of cells with fewer than five stress fibers
or focal adhesions was calculated. The experiments were repeated
twice and with two to three dishes per experiment.
Triton X-100 extraction
Two experimental techniques were used to assess the extractability of
b 1 integrin. Adherent cells were treated for 5 minutes on ice with
either 0.01% Triton X-100 in DMEM or, as previously described (Fey
et al., 1984), with 0.5% Triton X-100 in a cytoskeletal (CSK) buffer
(100 mM NaCl, 300 mM sucrose, 10 mM Pipes pH 6.8, 3 mM MgCl2,
0.5% Triton X-100 and 1.2 mM phenylmethylsulfonyl fluoride). Both
extraction conditions yielded similar results. The cells were
subsequently rinsed with PBS and incubated with polyclonal anti- b 1
integrin antibodies for 30 minutes, rinsed again and fixed with 4%
paraformaldehyde for 2 minutes. Secondary antibodies were applied
as described above. 
Cell attachment assays 
Nunc-Immuno 96-well plates with a MaxiSorp surface (Nunc A/S,
Roskilde, Denmark) were coated with 10 m g/ml 9EG7 rat anti-mouse
b 1 integrin antibody (BD Biosciences) or 10 m g/ml fibronectin in 0.1
M NaHCO3 buffer overnight at 4°C, rinsed with PBS and blocked
with 1% bovine serum albumin in PBS for 1 hour at 37°C. The plate
was washed once with PBS and 6 · 104 cells/well were added and
allowed to attach for 1 hour at 37°C in 5% CO2 in a humidified
atmosphere. For cell attachment assays, the plates were centrifuged
in an inverted position at 25 g for 2 minutes. Cells were washed twice
in serum-free DMEM, fixed for 20 minutes at room temperature in
2% glutaraldehyde in 0.1 M cacodylate buffer and stained with 0.1%
crystal violet in 10% methanol. Absorbance was measured with a
Multiscan ELISA reader (Lab-systems, Helsinki, Finland) at 590 nm.
Each assay was carried out in eight separate wells in each of two
repetitions.
Apoptosis assay
Cells were trypsinized and resuspended in growth medium with or
without 10 m g/ml of the b 1 integrin-activating antibody, 9EG7. After
incubation for 20 minutes at 37°C in suspension, cells were plated and
cultured for 20 hours. Cells were re-incubated with 9EG7 (10 m g/ml)
for 40 minutes immediately before treatment with tumour necrosis
factor (TNF)- a (Strathmann Biotec AG, Hamburg, Germany) (100
ng/ml) and cycloheximide (Sigma-Aldrich) (5 m M). After 5 hours of
TNF-a and cycloheximide treatment, cells were fixed with 4%
paraformaldehyde, permeabilized with 0.1% Triton X-100 and stained
with 4 ¢ ,6-diamidino-2-phenylindole dihydrochloride (DAPI) (10
mM). The number of apoptotic cells were assessed by fluorescence
microscopy (Higuchi et al., 2003). 
Flow cytometry 
Growing and confluent (day 0) LiSa-2 cells were detached with cell
dissociation buffer (Invitrogen) and restored for 5 minutes at 37°C in
growth medium supplemented with 10% FBS, then transferred to ice
and washed twice in cold washing buffer (PBS supplemented with
1% BSA). Mouse anti-human 12G10 and MAR4 were diluted
according to the description of the manufacturer and added to the
cell suspension. After 20 minutes at 4°C, cells were washed twice
with washing buffer, incubated with the secondary antibody
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(phycoerythrin-conjugated goat anti-mouse IgG) for 20 minutes at
4°C and rinsed twice in washing buffer. After the second wash, cell
pellets were resuspended in 500 m l washing buffer. Flow cytometric
analyses were performed according to standard settings on a FACStar
PLUS flow cytometer with CELLQUEST software (both from BD
Biosciences).
RNA interference and microinjection
Short interfering RNA (siRNA) oligos were purchased from
Dharmacon (Lafayette, CO) in a 2¢ -deprotected, desalted, single-
stranded form (option B), and annealed according to the
manufacturer’s protocol. Oligo sequences were: AAUCCCACGAC-
AAUGCUCAGCdTdT (mouse ADAM12 siRNA), and AACGACG-
UCCACUCUACAGCAdTdT (scrambled siRNA). A mixture of
siRNA (2 m M) and EGFP expression vector (0.1 m g/m l) was injected
into 3T3-L1 cells using a FemtoJet microinjector and an Inject Man
NI 2 manipulator (Eppendorf, Hamburg, Germany) at an injection
pressure of 150 hPa and an injection time of 0.7 second. Confluent
cells were injected, and differentiation was induced the following day
as described above. At day 4 after differentiation, cells were processed
for phalloidin staining or immunostaining with antibodies to
ADAM12 and observed under a fluorescence microscope. 
Statistical analysis 
All data are expressed as means – s.e. The unpaired Student’s t-test
or the Mann Whitney test was used for comparisons. A value of
P≤0.05 was considered statistically significant.
Results
Expression of ADAM12 in adipose tissue and during in
vitro adipogenesis 
We have previously shown that ADAM12 stimulates
adipogenesis in a transgenic mouse model (Kawaguchi et al.,
2002). Here, we investigated the potential mechanisms
underlying this observation. First, the expression profile of
ADAM12 was determined in normal adipose tissue and during
adipogenesis in vitro. ADAM12 was detected by
immunostaining in normal mouse white and brown adipose
tissue (Fig. 1A,C). We were unable to detect ADAM12 in
normal human adipose tissue (data not shown), but ADAM12
was expressed in lipomas, which are benign tumors of human
white adipose tissue (Fig. 1B) and hibernomas, which are
benign tumors of human brown adipose tissue (Fig. 1D).
Expression of ADAM12 mRNA in abdominal and epididymal
white adipose tissue, as well as in brown adipose tissue from
normal mouse, was demonstrated by northern blotting (Fig.
1E). Similarly, two murine preadipogenic cell lines, 3T3-L1
and C3H10T1/2, and the human liposarcoma cell line, LiSa-2,
all expressed ADAM12 mRNA (Fig. 2A,C and data not
shown). The temporal expression of ADAM12 and PPAR g
mRNA was determined in growing fibroblastic preadipocytes,
in confluent preadipocytes at the time of induction of
differentiation (day 0), and at days 4 and 9 following induction
(the period of fat vacuole accumulation). The level of
expression of the adipogenic marker PPAR g was low at day 0
and several fold higher at day 9, as expected (Fig. 2B). The
level of ADAM12 mRNA expression was highest at day 0 and
decreased during the process of adipogenic differentiation (Fig.
2B). Fig. 2B also shows that ADAM12 was transiently
upregulated at day 0 and decreased thereafter. Thus, the
expression of PPAR g and ADAM12 appears to be inversely
correlated in the 3T3-L1 cells. Similarly, expression of
ADAM12 mRNA in LiSa-2 cells appeared to decline during
adipogenesis (Fig. 2C). ADAM12 protein expression in all
three cell lines was confirmed by western blot (Fig. 2D).
Cell-surface expression of ADAM12 before the onset of
adipogenesis
To study the subcellular distribution pattern of ADAM12
during different stages of 3T3-L1 adipogenesis,
permeabilized adherent cells were immunostained (Fig. 3A-
C). Growing cells displayed mostly intracellular staining
(Fig. 3A), whereas day 0 confluent cells showed a distinct
cell-surface staining (Fig. 3B). Most maturing adipocytes
(day 4) exhibited intense cytoplasmic ADAM12 staining,
which was confined to small separate vacuoles that probably
represented late endosomes or lysosomes (Fig. 3C).
The number of adipocytes with intracellular ADAM12
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Fig. 1. ADAM12 expression in adipose tissues. (A-D) ADAM12
expression was demonstrated by immunostaining (arrows) in white
adipose tissue from a normal mouse (A), in a human lipoma (B), in
mouse brown and white adipose tissue (C), and in a human
hibernoma (D). (E) The expression of ADAM12 mRNA in mouse
abdominal (Ab)-, epididymal (Ep)- white adipose tissue (WAT) and
brown adipose tissue (BAT), was shown by northern blot analysis.
Normal adult muscle and embryonic muscle (E17) were used as
negative and positive controls, respectively. The expression of
GAPDH was analyzed as a loading control. The brownish color
represents the positive immunostaining reaction product, and the blue
color is hematoxylin counterstaining. Bars, 20 m m (A,B) and 30 m m
(C,D).
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immunostaining decreased in later stages of differentiation
(after 6-8 days, data not shown). 
To more rigorously establish the cell-surface localization of
ADAM12, suspended cells were immunostained for ADAM12
without previous permeabilization (Fig. 3D-F). Growing cells
had little or no detectable cell-surface immunostaining (Fig.
3D). By contrast, day 0 cells had distinct, evenly distributed
cell-surface staining (Fig. 3E). During the adipogenic stage
(the 4 days following induction), maturing adipocytes
exhibited cell-surface staining that was clearly fainter than the
staining of day 0 cells (Fig. 3F). A similar temporal pattern of
ADAM12 expression was observed in mouse C3H10T1/2 and
in human LiSa-2 cells (data not shown). 
The dynamic subcellular localization of ADAM12 during
adipogenesis indicated that the protein is endocytosed after the
onset of differentiation. To test this hypothesis, anti-ADAM12
IgG (a mixture of mAbs, 6E6, 6C10, 8F8; 7.5 m g total) or
control IgG (7.5 m g) was incubated with growing 3T3-L1 cells.
After 5 hours, 2 days or 6 days, the cultures were rinsed, fixed,
permeabilized and stained with secondary antibody to detect
the ADAM12:IgG complex (Fig. 3G-I). No ADAM12:IgG was
detected in growing cell cultures (Fig. 3G); however, cell-
surface ADAM12:IgG was detected in confluent preadipocytes
(Fig. 3H). In day 4 cultures, ADAM12:IgG was located
intracellularly (Fig. 3I). No intracellular staining was observed
when control IgG was added (data not shown). These results
suggest that ADAM12 is, in fact, endocytosed during adipocyte
differentiation. 
Together, these results indicate that the subcellular
distribution of ADAM12 is highly regulated: ADAM12 is
translocated to the cell surface of preadipocytes before the
onset of differentiation, and internalized during adipogenesis. 
Formation of ADAM12/b 1 integrin complexes and
reduced b 1 integrin activity as assessed by 12G10
immunostaining upon ADAM12 cell-surface localization
Under nonadipogenic conditions, fibronectin in the ECM (Fig.
4A) and intracellular actin stress fibers in preadipocytic cells
(Fig. 4B) appear to be arranged in parallel, most probably with
b 1 integrins as coordinating matrix points at the cell surface
(Fig. 4C). Because ADAM12 can interact with b 1 integrins in
trans, i.e. ADAM12 present on one cell may bind to the integrin
present on another cell (Eto et al., 2000), we hypothesized that
ADAM12 itself could be part of a b 1 integrin cell-adhesion
complex and that this might influence the adipogenic
differentiation pathway. To test this hypothesis, we performed
co-immunoprecipitation experiments using antibodies against
ADAM12 followed by western blotting with antibodies against
b 1 integrin. As shown in Fig. 4D, ADAM12 and b 1 integrin
formed complexes in LiSa-2, C3H10T1/2 and 3T3-L1 cells.
The localization pattern of b 1 integrin at the cell surface was
examined by immunostaining and fluorescence-activated cell
sorter (FACS) analysis (Fig. 5). Growing LiSa-2 cells showed
prominent b 1 integrin cell-surface immunostaining using
antibodies to the activated human b 1 integrin (12G10) (Fig.
5C). Less intense b 1 integrin immunostaining was detected on
confluent day 0 cells stained in parallel (Fig. 5D), which was
confirmed by FACS analysis (Fig. 5G). There was little or no
detectable difference in the total amount of b 1 integrin as
determined by immunostaining using the K20 antibody (Fig.
5E,F), or by FACS analysis using the MAR4 antibody against
b 1 integrin (Fig. 5H).
These results indicate that upon ADAM12 cell-surface
expression, b 1 integrin/ADAM12 complexes are formed,
which appears to result in reduced b 1 integrin activity. To
assess the consequences of reduced b 1 integrin activity,
potential changes in cell shape, actin cytoskeleton
organization, cell adhesion, organization of ECM and cell
survival were evaluated. 
Cell-surface ADAM12 induces actin cytoskeleton re-
organization 
Concomitant with the onset of adipocyte differentiation,
the fibronectin-rich ECM becomes degraded, the actin
cytoskeleton undergoes a dramatic reorganization and the cell
Fig. 2. ADAM12 mRNA expression is transiently upregulated before
adipocyte differentiation. (A) Total RNA was extracted from mouse
3T3-L1 cell cultures at various times during differentiation. The
levels of ADAM12, PPARg and GAPDH mRNA expression were
analyzed by northern blot. GAPDH and rRNA served as loading
controls. (B) Quantitative analysis of ADAM12 and PPARg mRNA
expression, normalized to GAPDH mRNA levels. (C) Northern blot
analysis of ADAM12 RNA extracted from human liposarcoma-
derived LiSa-2 cells at various stages of differentiation.
(D) ADAM12 protein expression was analyzed by western blot in
extracts from growing C3H10T1/2, 3T3-L1 and LiSa-2 cells. CHO-
K1 cells transfected with control vector and full-length mouse
ADAM12 cDNA were used as negative (NC) and positive (PC)
controls, respectively. D0, day 0 confluent cells; D3, D4, D9 and
D17, days 3, 4, 9 and 17 after the onset of differentiation,
respectively; G, growing fibroblastic cells.
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shape changes (Cornelius et al., 1994). Growing preadipocytes
have a fibroblastic morphology and exhibit an elaborate
network of stress fibers (Fig. 6A). At day 0 the preadipocytic
cells are closely packed, and some begin to round up and loose
their actin stress fibers (Fig. 6B). Within 4 days after induction
of differentiation, maturing adipocytes are round, the actin
stress fibers have disappeared and have reorganized into a
cortical actin network located just beneath the cell membrane
(Kanzaki and Pessin, 2001) (Fig. 6C). To determine whether
ADAM12 influences the early changes in the organization of
the actin cytoskeleton, growing 3T3-L1 preadipocytes were
transfected with ADAM12-D cyt. This construct allows the
efficient translocation of ADAM12 to the cell surface in
contrast to the full-length ADAM12-L construct, which results
in a predominantly intracellular accumulation of protein
(Hougaard et al., 2000). ADAM12- D cyt, therefore, provides a
good model to study the effect of ADAM12 at the cell surface.
Two days after transfection with ADAM12- D cyt, the cell
morphology had changed dramatically. Transfected cells were
smaller, and more rounded. They retracted their cytoplasm, and
their actin stress fibers gradually disappeared and were
replaced, first by dot-like actin elements, then by a distinct
cortical localization of actin (Fig. 6D-F). Cells transfected with
a protease-deficient ADAM12-D cyt construct (ADAM12-D cyt
cat mut) had the same morphological appearance as cells
transfected by ADAM12- D cyt, i.e. the actin stress fibers in
these cells disappeared and re-organized into a cortical
localization (Fig. 6G-I). Cells transfected with a control EGFP
vector maintained their stress fibers and did not exhibit
morphological changes (Fig. 6J-L).
To test whether endogenous ADAM12 in preadipocytes
influences reorganization of the actin cytoskeleton, we used
an RNAi strategy to reduce ADAM12 expression. Confluent
3T3-L1 preadipocytes were microinjected with ADAM12 or
scrambled siRNA oligos together with EGFP to identify
injected cells, and differentiation was induced the following
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Fig. 3. Distinct upregulation of ADAM12 at the
cell surface before onset of 3T3-L1 adipocyte
differentiation. Growing cells are shown in (A)
and (D), confluent (day 0) cells in (B) and (E),
and maturing cells after 4 days of differentiation
in (C) and (F). (A-C) Adherent cells were
immunostained after permeabilization. (D-
F) Cells were immunostained in suspension
without previous permeabilization, then
subjected to cytospin centrifugation, as
described in Materials and Methods.
(G-I) ADAM12 mAbs were added to the
cultures for 5 hours (G) 2 days (H) and 6 days
(I), followed by detection of the ADAM12:IgG
complex with a secondary Ab to visualize
endocytosed ADAM12. The central red staining
in the cells in panels A and B represent
nonspecific nuclear immunoreactivity. Bars, 18
m m (A,B,D,E,G,H) and 30 m m (C,F,I). 
Fig. 4. Coordinated localization of fibronectin,
actin stress fibers, b 1 integrin and co-
immunoprecipitation of ADAM12 and b 1 integrin.
Immunostaining of fibronectin (A), F-actin (B) and
b 1 integrin (C) in growing LiSa-2 cells. Fibronectin
staining outside the cells and actin stress fibers
inside the cells are parallel to each other, with the
cell-surface b 1 integrin receptor localized at the
matrix points. (D) Co-immunoprecipitation of
ADAM12 and b 1 integrin from cell extracts of
LiSa-2 (lane 3), C3H10T1/2 (lane 5) and 3T3-L1
(lane 7) cells. For this experiment, cell extracts
were immunoprecipitated with monoclonal
antibodies to ADAM12 (lanes 3,5,7) or control IgG
(lanes 2,4,6), and complexes were examined by
western blotting with monoclonal antibodies to
human b 1 integrin JB1A (lanes 2,3) and to mouse
b 1 integrin clone 18 (lanes 4-7). Lane 1 is a direct
western blot of b 1 integrin in LiSa-2 cell lysate
using the JB1A monoclonal antibody. Bar, 6 m m. 
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day. On day 4 of differentiation, cell cultures were fixed and
examined with phalloidin staining to monitor F-actin. 3T3-
L1 cells microinjected with ADAM12 siRNA maintained
their stress fibers (Fig. 7B), whereas cells injected with
scrambled siRNA were similar in appearance to the
surrounding noninjected cells and did not contain stress fibers
(Fig. 7D). To confirm that the microinjected ADAM12 siRNA
reduced the expression of ADAM12, these cells were
immunostained and ADAM12 immunostaining was not seen
in any injected cells (Fig. 7E,F), whereas noninjected cells
exhibited positive ADAM12 immunostaining (Fig. 7G,H). As
a further control, cells injected with scrambled siRNA also
exhibited positive ADAM12 immunostaining (data not
shown).
Cells with increased cell-surface ADAM12 expression
are less adhesive, are more prone to apoptosis and
have a reorganized extracellular fibronectin matrix
We used retroviral transduction to establish a 3T3-L1 cell line
that constitutively expressed ADAM12- D cyt at the surface
(Fig. 8A,B), and confirmed protein expression by western
blot (Fig. 8C). These cells, like preadipocytes transiently
transfected with ADAM12-D cyt (see Fig. 6D), showed fewer
stress fibers compared with cells infected with a control vector
(Fig. 8D,E). Compared with the control cells, a significantly
higher percentage of the ADAM12- D cyt-expressing cells had
fewer than five stress fibers (Fig. 8F). As shown in Fig. 8G-I,
the ADAM12- D cyt-expressing cells also exhibited a marked
reduction in vinculin-positive focal adhesions, suggesting
reduced b 1 integrin-mediated adhesion activity when
ADAM12-D cyt is expressed at the cell surface. We therefore
tested the capacity of these cells to attach to 9EG7 mAb, to
mouse b 1 integrin (data not shown) and to fibronectin (Fig. 8J)
in cell attachment assays. The 3T3-L1 cells expressing
ADAM12-D cyt were significantly less adhesive than 3T3-L1
cells that did not express ADAM12- D cyt (Fig. 8J). The same
results were obtained with C3H10T1/2 cells infected with
ADAM12-D cyt (data not shown). These results led us to test
whether ADAM12-D cyt might also influence b 1 integrin-
mediated cell survival pathways. As shown in Fig. 9A,B, 3T3-
L1 cells overexpressing ADAM12- D cyt are more sensitive to
TNF-a -induced apoptosis than are control cells. It should be
noted that this effect of ADAM12- D cyt was also observed
in other cell types, including CHO-K1 cells (U.M.W.,
unpublished). The increased sensitivity to apoptosis was
prevented by the b 1 integrin-activating mAb 9EG7 (Fig. 9C). 
Finally, the organization of the pericellular fibronectin-rich
ECM was analyzed in 3T3-L1/ADAM12- D cyt cells. We found
that the fibronectin-matrix of these ADAM12-D cyt-expressing
cells no longer appeared as an extensive, dense network, as in
the control fibroblastic preadipocytes (Fig. 9E), but instead was
distributed as a dense basement membrane-like rim encircling
the cell borders (Fig. 9D). 
Together, these results indicate that ADAM12-D cyt induces
a negative regulation of typical b 1 integrin functions.
ADAM12 increases the Triton X-100 solubility of b 1
integrin 
It is well known that integrins associate with the actin
cytoskeleton and modulate cell shape – for example, during
formation of filopodia and lamellopodia. The findings
described above suggest that ADAM12 induces changes in the
association between b 1 integrin and the actin cytoskeleton. To
test this hypothesis, the Triton X-100 extractability of b 1
integrin was examined. We used two different experimental
procedures: one was the standard 0.5% Triton X-100 in CSK
buffer and the other was 0.01% Triton X-100 in DMEM. Under
both experimental conditions ADAM12- D cyt-expressing 3T3-
L1 cells exhibited a dramatic reduction of b 1 integrin
immunostaining (Fig. 10A,E) compared with control 3T3-L1
cells, which exhibited intense b 1 integrin immunostaining (Fig.
10B,F). The b 1 integrin immunostaining in untreated
ADAM12-D cyt-expressing 3T3-L1 and control cells are shown
in Fig. 10C,D for comparison. Triton X-100 solubility of b 1
integrin is another demonstration of how overexpression of
Fig. 5. Reduced b 1 integrin activity upon ADAM12 cell-surface
localization. Cell-surface immunostaining of ADAM12 (A,B) and
activated b 1 integrin, clone 12G10 (C,D) or total b 1 integrin, clone
K20 (E,F) in growing cells (A,C,E) and in confluent day 0 cells
(B,D,F). Note the inverse relationship between cell-surface
localization of the activated form of b 1 integrin and ADAM12 at the
cell surface, while no apparent difference in the total amount of b 1
integrin was detected by immunostaining (compare E and F). This
was confirmed by FACS analysis using activated b 1 integrin, clone
12G10 (G) or total b 1 integrin, clone MAR4 (H). Growing cells and
day 0 cells were shown with gray and red, respectively. Bars, 25 m m
(A,B) and 20 m m (C-F).
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ADAM12- D cyt mimics the dynamic changes that accompany
early adipocyte differentiation (Fig. 10G,H). 
Discussion
Changes in morphology are a hallmark of terminal
differentiation. The present study provides novel insights into
the role of ADAM12 at the critical stage of early adipogenesis
in which fibroblastic preadipocytes change morphology and
commence differentiation to mature adipocytes. We have
provided direct evidence that ADAM12 induces alterations in
the actin cytoskeleton, cell adhesion, cell survival and the
fibronectin-rich ECM. Our data furthermore suggest that these
effects of ADAM12 are mediated by inhibition of b 1 integrin
function.
Several studies have pointed to an important role of ADAMs
during mesenchymal cell differentiation (Gilpin et al., 1998;
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Fig. 6. Cell-surface ADAM12 induces actin
cytoskeleton reorganization in 3T3-L1 cells.
(A-C) 3T3-L1 cells were analyzed by staining with
rhodamine-conjugated phalloidin to monitor F-actin
organization during differentiation. (D-L) Growing
3T3-L1 cells were transfected with plasmids encoding
ADAM12-D cyt/EGFP (D-F), ADAM12-D cyt catalytic
site mutation/EGFP (G-I) or vector control (J-L) and
analyzed for EGFP (D,G,J), F-actin (E,H,K) and by
phase-contrast microscopy (F,I,L). Cytoskeletal
organization was disrupted in cells transfected with
either ADAM12-D cyt or ADAM12- D cyt with a
catalytic site mutation (E,H), whereas actin stress
fibers were maintained in cells transfected with the
vector control (K). Single and double arrows indicate
actin stress fibers and cortical actin, respectively. Bars,
10 m m (A-C) and 7 m m (D-L).
Fig. 7. Decreased expression of ADAM12 in 3T3-L1 cells by RNAi
inhibits actin cytoskeleton reorganization. 3T3-L1 cells were co-
injected with ADAM12 siRNA (A,B) or a scrambled siRNA oligo
(C,D) together with a control EGFP vector. Cells were analyzed for
EGFP by direct fluorescence microscopy (A,C) or for F-actin by
staining with rhodamine-conjugated phalloidin (B,D). Cells injected
with ADAM12 siRNA (B) maintained their stress fibers (single
arrow), whereas cells injected with scrambled siRNA (D) did not
contain stress fibers and showed cortical actin instead (double
arrows). As a control siRNA-injected, EGFP-positive cells (E) did
not exhibit ADAM12 immunostaining (F), whereas noninjected cells
(G) did exhibit ADAM12 immunostaining (H). Bars, 8 m m.
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Yagami-Hiromasa et al., 1995). In the mouse embryo,
ADAM12 is most prominently expressed in condensed
mesenchymal cells in regions of muscle and bone formation,
including cranial membranous bones, ribs and limbs, and in the
bone marrow (Kurisaki et al., 1998). ADAM12 expression is
not detectable in adult skeletal muscle; however, expression is
upregulated during muscle regeneration (Galliano et al., 2000).
Interestingly, ADAM12 has been shown to alleviate the
pathology of the dystrophin-deficient mdx mice (Kronqvist et
al., 2002). Furthermore, transgenic mice overexpressing
ADAM12 show increased adipogenesis (Kawaguchi et al.,
2002), whereas ADAM12-deficient mice showed decreased
interscapular brown adipose tissue (Kurisaki et al., 2003). In
the present study we examined the expression profile of
ADAM12 during adipogenesis. We found that ADAM12
mRNA was detected throughout most stages of adipogenesis
but was present at maximal levels in confluent preadipocytes
just before the onset of differentiation. These committed
preadipocytes were characterized by increased levels of
ADAM12 immunostaining at the cell surface that was present
in complexes with b 1 integrin. ADAM12 mRNA expression
decreased in later stages of adipogenesis, and ADAM12
located at the cell-surface disappeared, which was most
probably due to endocytosis. 
Adhering fibroblastic cells, including preadipocytes, are
characterized by an elaborated network of stress fibers and
focal adhesions and show an intense cell-surface b 1 integrin
immunostaining with 12G10 mAb. As preadipocytes become
confluent and round up, their stress fibers become reorganized
into a cortical network and their adhesion to the ECM is
weakened. This is thought to be crucial for the subsequent
induction of adipogenic transcription factors. Direct evidence
Fig. 8. Focal adhesion formation and cell
adhesion are downregulated in 3T3-L1 cells
overexpressing ADAM12 at the cell surface. Cells
(suspended in A,B and adherent in D-J) with
constitutive expression of ADAM12-D cyt at the
cell surface (A,D,G) and control cells (B,E,H)
were examined. (A-C) ADAM12 immunostaining
and western blot analysis. (D-F) Staining with rhodamine-conjugated
phalloidin to monitor F-actin organization (D,E) showed that
ADAM12- D cyt-expressing cells were smaller than control cells, and
that, compared with the control cells, a significantly higher
percentage of cells had fewer than five stress fibers (P<0.02) (F).
(G-I) Vinculin immunostaining (G,H) showed that a higher
percentage of ADAM12-D cyt expressing cells than control cells had
fewer than five focal adhesions (P<0.02) (I). (J) Compared with the
control cells, cell attachment on fibronectin was reduced (P<0.01) in
ADAM12-D cyt-expressing cells. Bars, 10 m m (A,B) and 15 m m
(D,E,G,H).
Fig. 9. Increased apoptosis and reorganized fibronectin-rich
extracellular matrix in 3T3-L1 cells overexpressing ADAM12 at the
cell surface. ADAM12- D cyt-expressing cells and control cells were
treated with cycloheximide and TNF-a to induce apoptosis, and
stained with DAPI, and the number of apoptotic cells was counted
(A-C). ADAM12-D cyt-expressing cells were more prone to apoptosis
(A) than were control cells (B). Apoptotic cells (fragmented nuclei)
are indicated by arrows. In C, the effect of b 1-activating antibody
9EG7 on TNF- a -induced apoptosis was examined. Apoptosis in
ADAM12-D cyt expressing cells (black columns) could be prevented
by 9EG7 (*P<0.01), whereas the antibody had no effect on control
cells (hatched columns). Fibronectin matrix assembly was altered in
ADAM12-D cyt-expressing cells (D) compared with control cells (E).
Bars, 5 m m (A,B) and 12 m m (D,E). 
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that ADAM12 is critically involved in the process of
reorganization of stress fibers was obtained from experiments
in which ADAM12- D cyt was overexpressed in 3T3-L1
preadipocytes by either transient transfection or by retroviral
transduction. Thus, fibroblastic cells overexpressing
ADAM12-D cyt attained a rounded morphology, and their actin
stress fibers disappeared and reorganized into a distinct F-actin
cortical localization, even before they reached confluence.
Furthermore, we found that 3T3-L1 preadipocytes
microinjected with ADAM12 siRNA oligos maintained their
stress fibers even 4 days after the induction of adipogenic
differentiation.
We hypothesized that the effect of ADAM12-D cyt on the
actin cytoskeleton is mediated through b 1 integrin, and
therefore asked whether other typical integrin-mediated
functions were also altered. We found that ADAM12-
expressing cells had decreased 12G10 immunostaining at
the cell surface, had fewer vinculin-positive focal adhesions
and adhered less efficiently to b 1 integrin antibodies and
fibronectin. Even integrin-mediated cell-survival pathways
appeared to be altered – that is, cells overexpressing ADAM12-
D cyt were more prone to TNF a -induced apoptosis (Fig. 9) as
well as apoptosis induced by ultraviolet light and thapsigargin
(U.M.W., unpublished). The finding that 9EG7 mAb could
prevent TNF-a -induced apoptosis in 3T3-L1 cells presents
strong evidence that this effect of ADAM12-D cyt is, in fact,
mediated through b 1 integrin. 
In other cell systems, it has been shown that the interaction
between ADAMs and b 1 integrin is mediated through the
disintegrin or cysteine-rich domains. For example, the
disintegrin domains of ADAM2 and 9 supports cell adhesion
through a 6b 1 integrin (Chen et al., 1999; Nath et al., 2000),
and that of ADAM12 through a 9b 1 integrin (Eto et al., 2000).
The recombinant cysteine-rich domain of ADAM12, however,
interacts with syndecans and mediates integrin-dependent cell
spreading (Iba et al., 2000). The intriguing role of the cysteine-
rich domain was elucidated further in a recent study on
ADAM13 (Smith et al., 2002) in which the authors showed that
this domain could cooperate intramolecularly with the
metalloprotease domain to regulate its function in vivo. Further
studies are needed to determine which of these adhesion
domain(s) of ADAM12 are involved in mediating b 1 integrin-
mediated changes in cell behavior.
ADAM12 induced a reorganization of the fibronectin-rich
ECM – that is, preadipocytes overexpressing ADAM12- D cyt
showed reduced fibronectin-rich ECM that was organized into
a basement membrane-like rim encircling the cells while
control preadipocytes maintained an elaborate meshwork of
fibronectin-rich ECM covering the cells. This is an important
finding as reduction of the fibronectin-rich ECM is a crucial
determinant for adipose differentiation. The role of the ECM
in adipogenesis was first suggested in 1983 when it was
reported that adipogenesis was inhibited in preadipocytes
grown on fibronectin-coated dishes (Spiegelman and Ginty,
1983). Subsequent studies showed that transforming growth
factor (TGF)- b inhibits adipogenesis by increasing the
expression of fibronectin and collagen (Bortell et al., 1994).
More recent studies have pointed to an important role for
matrix metalloproteases (MMPs)-2 and -9 and plasmin in
promoting adipogenesis by degrading the fibronectin-rich
ECM (Alexander et al., 2001). Although, on the basis of the
studies presented here, we suggest that the effect of ADAM12
on the reorganization of the fibronectin-rich ECM is mediated
via the reduced activity of b 1 integrin, we cannot exclude the
contribution of the metalloprotease activity of ADAM12. Little
is known about the physiological substrate for the ADAM12
protease, although it was recently proposed to cleave heparin-
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Fig. 10. Altered extractability of b 1 integrin in Triton X-100 in 3T3-
L1 cells overexpressing ADAM12 at the cell surface. Adherent 3T3-
L1 ADAM12- D cyt cells and control 3T3-L1 cells treated with 0.01%
Triton X-100 in DMEM (A,B) for 5 minutes on ice or left untreated
(C,D) and subsequently immunostained with polyclonal antibodies to
b 1 integrin (A-D). In parallel experiments, adherent 3T3-L1
ADAM12-D cyt cells (E) or control cells (F), or normal growing 3T3-
L1 cells (G) or confluent day 0 3T3-L1 cells (H) were extracted with
0.5% Triton X-100 in a physiological buffer (CSK) for 5 minutes on
ice, released from the plastic substrate with dissociation buffer and
immunostained with polyclonal antibodies to b 1 integrin in
suspension as described in Materials and Methods. Note that the
increase in b 1 integrin solubility, and hence, decreased
immunostaining in cells overexpressing ADAM12- D cyt (A,E) is
similar to that seen in normal confluent day 0 3T3-L1 cells (H)
compared with normal growing 3T3-L1 cells (G). Bars, 25 m m (A-D)
and 15 m m (E-H). 
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binding epidermal growth factor-like growth factor (HB-EGF)
in the mouse heart (Asakura et al., 2002). We have previously
shown that human ADAM12-S can degrade insulin-like growth
factor binding protein (IGFBP)-3 and IGFBP-5 (Loechel et al.,
2000; Shi et al., 2000). Transgenic mice expressing a form of
ADAM12-S lacking the prodomain and metalloprotease
domains (called ADAM12-S minigene) did not exhibit
increased adipogenesis (Kawaguchi et al., 2002), suggesting a
role for the protease activity of ADAM12 in adipogenesis. 
The data presented here strongly suggest that ADAM12 may
directly or indirectly influence the function of b 1 integrin. The
exact molecular mechanisms involved, however, warrant
further consideration. We found that b 1 integrin co-
immunoprecipitates with ADAM12, suggesting that these two
proteins can be part of the same adhesion complex. This
indicates that ADAM12 in-cis could modulate b 1 integrin
function through lateral associations, and this further raises the
interesting question as to whether ADAM12 may induce a
redistribution of b 1 integrins in the cell membrane, i.e. out of
the rafts or caveolae microdomains. In this context, the recent
demonstration that an extracellular matrix component, laminin-
2, could induce a colocalization of a 6b 1 integrins and platelet
derived growth factor (PDGF)a R into the same lipid rafts
during oligodendrocyte differentiation is of interest (Baron et
al., 2003). The exact localization of ADAM12 in the cell
membrane is not yet known, but ADAM10 ( a -secretase) seems
not to be present in lipid microdomains (Kojro et al., 2001).
Even if the exact localization of ADAM12 and b 1 integrin in
the membranes of these cells is not yet determined, it was
observed that the effect of the association between the two
proteins was to disengage b 1 integrin from the actin
cytoskeleton. This conclusion is based on the striking finding
that 0.5% Triton X-100 extracted b 1 integrin from ADAM12-
D cyt-expressing 3T3-L1 cells but not from control cells. 
The investigations described in this study focused on the role
of ADAM12 in early adipogenesis before the onset of terminal
differentiation. However, the ADAM family contains at least
33 members, and it is likely that other ADAMs function in
parallel with ADAM12 in a synergistic or antagonistic fashion.
Preliminary RT-PCR data showed that ADAM9, 10, 17 and 19
are also expressed in the 3T3-L1 cells during adipogenesis, and
additional immunochemical data demonstrated the expression
of ADAM15 (U.M.W., unpublished). The finding that
ADAM12 null mice do not exhibit striking defects in the white
adipose tissue (Kurisaki et al., 2003) further suggests
functional overlap among the ADAMs. Additional studies,
including those using double-knockout technology, are needed
to definitively determine the contribution of other ADAMs
during adipogenesis. 
In conclusion, the findings reported here show that
ADAM12 induces reorganization of the actin cytoskeleton,
reduced cell adhesion, changes in cell survival pathways and
reorganization of the fibronectin-rich ECM in fibroblastic
preadipocytes. Furthermore, our observations strongly suggest
that ADAM12 at the cell surface mediates its effects via a
direct or indirect interaction with b 1 integrin that results in an
impairment of b 1 integrin function, possibly by decreasing the
association of b 1 integrin with the actin cytoskeleton. These
results may have implications, not only for adipocyte
differentiation and maturation, but also for mesenchymal cell
differentiation in general.
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